Skip to content

THC vs. CBD: What You Need to Know

THC vs. CBD: What You Need to Know

With the rising demand of natural medicines, medical marijuana compounds THC and CBD are starting to make a name for themselves more than ever before. These two compounds have a wide range of health benefits, making it understandable why patients and physicians would be interested in this alternative treatment option. Although these two compounds are derived from the same source and appear to be virtually identical, they affect the human body quite differently.

Cannabinoids and the Endocannabinoid System

Before we dissect these two compounds, it’s important to understand where they come from and what part of the body they affect. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) are just two of the 85 known cannabinoids found in the Cannabis plant.

“A cannabinoid is a compound that interacts directly with our body’s Endocannabinoid System (ECS), which in short, is a network of receptors that interact with cannabinoids to maintain vital functions throughout our body.” (Medium.com/CBD-Origin).

In 1988, scientists discovered the first cannabinoid receptor, with the second coming to light in 1993. In 1995, these two receptors were identified as CB1 and CB2 receptors. “The interaction between the CB1 and CB2 receptors with cannabinoids like CBD and THC is the catalyst for health benefits such as pain relief, anxiety relief, appetite stimulation, mood management and more.”

Molecular Makeup

As far as chemical makeup goes, THC and CBD are the exact same: 21 carbon atoms, 30 hydrogen atoms and two oxygen atoms. Take a look at the figure below. The differentiator between the two compounds is the placement of one single atom through their structure. For reference, one atom is one million times smaller than a human hair, so we’re talking about a microscopic difference.

While a microscopic difference might not seem like a big deal, it’s exactly what makes these two compounds react with our body in surprisingly different ways. These different reactions are due to the fact that THC and CBD have different molecular structures, causing them to have dissimilar interactions with CB1 and CB2.

THC vs. CBD: How Each Affects the Body

Despite their near identical structures, THC and CBD differ when it comes to psychoactive effects. In fact, CBD is a non-psychoactive compound, meaning it doesn’t produce the “high” feeling associated with THC.

Due to its molecular structure, THC is able to bind strongly with CB1 receptors. When this bond is formed, the reaction creates signals that are then sent to the brain. These reactions are the core source of the well-known psychoactive response of “getting high”.

On the complete opposite side of the spectrum, CBD does not bond strongly with CB1 receptors and can even negate the bond between THC and the CB1 receptors. By doing this, those psychoactive effects induced by THC are completely neutralized.

“While THC certainly offers tremendous health benefits, its mind-altering effects aren’t preferred by everyone. CBD, on the other hand, can deliver many of the same benefits of THC without inducing its psychoactive effects. Plus, when using CBD vs THC, you typically won’t be breaking the law.” (Medium.com/CBD-Origin)

Are YOU ready to put CBD and THC to the test with your patients? Join Arfinn Med for FREE to get real medical marijuana treatment efficacies, discuss treatment options with other licensed physicians and stay up-to-date on all of the latest industry findings.

Looking for more information about CBD and THC? Check out these two articles to learn more about the health benefits and side effects:

https://medium.com/cbd-origin/cbd-vs-thc-the-difference-explained-b3cfc1da52f0

https://www.healthline.com/health/cbd-vs-thc#psychoactive-components

Stories you may be interested in

Research shows cannabis can lower opioid dosage, but studies are preliminary

Larson cited one statistic to justify his bill: “Studies have shown up to 75% reduction in opioid dosage for medical cannabis users” The intersection of medical cannabis and opioid use as treatments for chronic pain is an emerging field of research as more states loosen regulations on medical and recreational use of marijuana. But does…
Read More

Are You Prepared For Questions About Medical Cannabis?

With over 85% of Americans supporting legalizing medical cannabis, it’s inevitable that patients will begin asking their primary care doctors about its use and overall efficacy. Doctors and other medical professionals will be called upon to be ‘sense-makers’ for a treatment they never studied in medical school and have limited available research to draw upon. …
Read More

Combating Opioid Dependence

The opioid epidemic is a hot topic across the United States, along with the alternatives that could alleviate the tragic consequences the epidemic brings. Opioids, also known as narcotics, are strong prescription pain relievers such as oxycodone, hydrocodone and fentanyl. Although illegal, heroin is also considered to be an opioid. Most patients are introduced to…
Read More

More baby boomers use medical marijuana, but they want their doctors to get wise to the risks and benefits

Baby boomers’ marijuana use has edged upward in the past decade, but recent research suggests some still have a hard time getting a hold of the drug. Older adults want more education, more research and greater openness with their health-care providers about using medical marijuana, according to a qualitative study of older cannabis users and non-users in…
Read More

Three Key Voices in the Medical Marijuana Industry

As medical marijuana programs continue to expand throughout the United States, it is important to recognize some of the key voices throughout the industry that got us here. These individuals range from researches to physicians and even to patients who started their own advocacy group. Keep reading to learn about just three of the many…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

Leave a Comment

You must be logged in to post a comment.